These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 36002595)

  • 1. Differential proteomic analysis of plasma-derived exosomes as diagnostic biomarkers for chronic HBV-related liver disease.
    Ye B; Shen Y; Chen H; Lin S; Mao W; Dong Y; Li X
    Sci Rep; 2022 Aug; 12(1):14428. PubMed ID: 36002595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of von Willebrand factor as a biomarker of tumor development in hepatitis B virus-associated human hepatocellular carcinoma: a quantitative proteomic based study.
    Liu Y; Wang X; Li S; Hu H; Zhang D; Hu P; Yang Y; Ren H
    J Proteomics; 2014 Jun; 106():99-112. PubMed ID: 24769235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum protein biomarkers for HCC risk prediction in HIV/HBV co-infected people: a clinical proteomic study using mass spectrometry.
    Ke H; Yuan R; Liu H; Luo M; Hu H; Zhang E; Zhuang K; Yang Y; Yang R
    Front Immunol; 2023; 14():1282469. PubMed ID: 38022651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promoting effect of hepatitis B virus on the expressoin of phospholipase A2 group IIA.
    Zhu C; Song H; Shen B; Wu L; Liu F; Liu X
    Lipids Health Dis; 2017 Jan; 16(1):5. PubMed ID: 28077172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of PD-L1 gene polymorphisms and circulating sPD-L1 levels with HBV infection susceptibility and related liver disease progression.
    Xuan Hoan N; Thi Minh Huyen P; Dinh Tung B; Phuong Giang D; Tat Trung N; Tien Sy B; Thi Tuan N; Thi Ngoc Dung D; Reddy Pallerla S; Velavan TP; Hong Bang M; Huu Song L
    Gene; 2022 Jan; 806():145935. PubMed ID: 34478821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted Proteins Reveal Cathepsin D as a Novel Biomarker in Differentiating Hepatocellular Carcinoma from Cirrhosis and Other Liver Cancers.
    Chuaypen N; Sriphoosanaphan S; Vorasittha A; Pinjaroen N; Chaiyarit S; Thongboonkerd V; Tangkijvanich P; Sirichindakul P
    Asian Pac J Cancer Prev; 2022 Jun; 23(6):2017-2025. PubMed ID: 35763644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor necrosis factor-α-induced protein 8-like 2 mRNA in peripheral blood mononuclear cells is associated with the disease progression of chronic hepatitis B virus infection.
    Liu Y; Jin J; Ji J; Gao XM; Fan YC
    Virol J; 2019 Oct; 16(1):120. PubMed ID: 31661000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomic analysis of differentially expressed proteins in hepatitis B virus-related hepatocellular carcinoma tissues.
    Li N; Long Y; Fan X; Liu H; Li C; Chen L; Wang Z
    J Exp Clin Cancer Res; 2009 Aug; 28(1):122. PubMed ID: 19715608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of miR-212 and Other Biomarkers in the Diagnosis and Treatment of HBV-infection-related Liver Diseases.
    Zhang Y; Xi H; Nie X; Zhang P; Lan N; Lu Y; Liu J; Yuan W
    Curr Drug Metab; 2019; 20(10):785-798. PubMed ID: 31608838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Profiles of serum microRNAs; miR-125b-5p and miR223-3p serve as novel biomarkers for HBV-positive hepatocellular carcinoma.
    Giray BG; Emekdas G; Tezcan S; Ulger M; Serin MS; Sezgin O; Altintas E; Tiftik EN
    Mol Biol Rep; 2014 Jul; 41(7):4513-9. PubMed ID: 24595450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conservation and variability of hepatitis B core at different chronic hepatitis stages.
    Yll M; Cortese MF; Guerrero-Murillo M; Orriols G; Gregori J; Casillas R; González C; Sopena S; Godoy C; Vila M; Tabernero D; Quer J; Rando A; Lopez-Martinez R; Esteban R; Riveiro-Barciela M; Buti M; Rodríguez-Frías F
    World J Gastroenterol; 2020 May; 26(20):2584-2598. PubMed ID: 32523313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered expression of A20 gene in peripheral blood mononuclear cells is associated with the progression of chronic hepatitis B virus infection.
    Fan YC; Zhang YY; Sun YY; Wang N; Xiao XY; Wang K
    Oncotarget; 2016 Oct; 7(42):68821-68832. PubMed ID: 27634895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative proteomic analysis of exosome protein content changes induced by hepatitis B virus in Huh-7 cells using SILAC labeling and LC-MS/MS.
    Zhao X; Wu Y; Duan J; Ma Y; Shen Z; Wei L; Cui X; Zhang J; Xie Y; Liu J
    J Proteome Res; 2014 Dec; 13(12):5391-402. PubMed ID: 25265333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Omega-6-derived oxylipin changes in serum of patients with hepatitis B virus-related liver diseases.
    Lu Y; Fang J; Zou L; Cui L; Liang X; Lim SG; Dan YY; Ong CN
    Metabolomics; 2018 Jan; 14(3):26. PubMed ID: 30830341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long non-coding RNA LINC01793 as a potential diagnostic biomarker of hepatitis B virus-related hepatocellular carcinoma.
    Mo C; Wu J; Sui J; Deng Y; Li M; Cao Z; Hu Z; Huang J; Li S
    Clin Biochem; 2022 Oct; 108():56-62. PubMed ID: 35760369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble fibrinogen-like protein 2 levels in patients with hepatitis B virus-related liver diseases.
    Van Tong H; Van Ba N; Hoan NX; Binh MT; Quyen DT; Son HA; Van Luong H; Quyet D; Meyer CG; Song LH; Toan NL; Velavan TP
    BMC Infect Dis; 2018 Nov; 18(1):553. PubMed ID: 30419833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Tandem mass tag-based quantitative proteomics analysis of plasma and plasma exosomes in Parkinson's disease].
    Zhao Y; Liu X; Zhang Y; Zhang J; Liu X; Yang G
    Se Pu; 2023 Dec; 41(12):1073-1083. PubMed ID: 38093537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteome Differences between Hepatitis B Virus Genotype-B- and Genotype-C-Induced Hepatocellular Carcinoma Revealed by iTRAQ-Based Quantitative Proteomics.
    Wei D; Zeng Y; Xing X; Liu H; Lin M; Han X; Liu X; Liu J
    J Proteome Res; 2016 Feb; 15(2):487-98. PubMed ID: 26709725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inter-alpha-trypsin inhibitor heavy chain H4 as a diagnostic and prognostic indicator in patients with hepatitis B virus-associated hepatocellular carcinoma.
    Noh CK; Kim SS; Kim DK; Lee HY; Cho HJ; Yoon SY; Lee GH; Hyun SA; Kim YJ; Kim HJ; Hwang JA; Ahn SJ; Shin SJ; Lee KM; Yoo BM; Cho SW; Cheong JY
    Clin Biochem; 2014 Sep; 47(13-14):1257-61. PubMed ID: 24836184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression profiling of serum microRNA-101 in HBV-associated chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma.
    Xie Y; Yao Q; Butt AM; Guo J; Tian Z; Bao X; Li H; Meng Q; Lu J
    Cancer Biol Ther; 2014 Sep; 15(9):1248-55. PubMed ID: 24971953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.